150 related articles for article (PubMed ID: 17383165)
1. Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state.
Grove M; Müllertz A; Pedersen GP; Nielsen JL
Eur J Pharm Sci; 2007 May; 31(1):8-15. PubMed ID: 17383165
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.
Grove M; Pedersen GP; Nielsen JL; Müllertz A
J Pharm Sci; 2005 Aug; 94(8):1830-8. PubMed ID: 15986460
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.
Nielsen FS; Petersen KB; Müllertz A
Eur J Pharm Biopharm; 2008 Jun; 69(2):553-62. PubMed ID: 18294829
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
Wang Y; Sun J; Zhang T; Liu H; He F; He Z
Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
8. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
10. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
11. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
Woo JS; Song YK; Hong JY; Lim SJ; Kim CK
Eur J Pharm Sci; 2008 Feb; 33(2):159-65. PubMed ID: 18178070
[TBL] [Abstract][Full Text] [Related]
12. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A
J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281
[TBL] [Abstract][Full Text] [Related]
13. Self-microemulsifying drug delivery system for improved oral bioavailability of dipyridamole: preparation and evaluation.
Guo F; Zhong H; He J; Xie B; Liu F; Xu H; Liu M; Xu C
Arch Pharm Res; 2011 Jul; 34(7):1113-23. PubMed ID: 21811918
[TBL] [Abstract][Full Text] [Related]
14. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.
Kang BK; Lee JS; Chon SK; Jeong SY; Yuk SH; Khang G; Lee HB; Cho SH
Int J Pharm; 2004 Apr; 274(1-2):65-73. PubMed ID: 15072783
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
[TBL] [Abstract][Full Text] [Related]
16. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
17. The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems.
Sun M; Si L; Zhai X; Fan Z; Ma Y; Zhang R; Yang X
Drug Dev Ind Pharm; 2011 Aug; 37(8):986-94. PubMed ID: 21417621
[TBL] [Abstract][Full Text] [Related]
18. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
Sek L; Boyd BJ; Charman WN; Porter CJ
J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
[TBL] [Abstract][Full Text] [Related]
19. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]